Researchers find that pancreatic cancer cell signals reprogrammed macrophages to suppress immune response and fuel tumor ...

The tumor microenvironment (TME) is a metabolically dynamic niche where cancer cells and immune cells interact to influence tumor progression and immune ...

Carnegie Mellon received $28.5 million to develop liver tissue bioprinting, with hopes it can reduce the need for transplants ...

In Argentina, equine cloning in polo is no longer a rarity. It’s now a mature industry — although ethical dilemmas ...

T cells are central mediators of autoimmune disease pathogenesis, yet their functional states are not defined solely by antigen recognition or canonical ...

Researchers from New England Biolabs (NEB®) and Yale University describe the first fully synthetic bacteriophage engineering ...

The strategy, known as synthetic biology, is gaining momentum globally as a conservation tool and human health solution, ...

The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With ...

Orikine Bio Appoints Larry Edwards as Chairman of the Board  BARCELONA, Spain, January 20, 2026 / Biotech Newswire / -- Orikine Bio, a biotechnology company based at the Barcelona Science Park (PCB-UB ...

The conversation around longevity is shifting. For decades, the goal was simple: live longer. But as medicine advances and ...

CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...

Identification of a nitric oxide-regulated transitional state of Müller glia reveals a key mechanism enabling neuronal regeneration in the injured vertebrate retina.